Skip to main content

Table 4 Disease free and overall survival rate at 4, 48 years in patients with positive staining vs. patients with negative staining for receptors of Growth Hormone.

From: Detection of somatostatin receptors in human osteosarcoma

  Patients with Positive staining for receptors of Growth Hormone
(Frequency/Percent)
Patients with Negative staining for receptors of Growth Hormone
(Frequency/Percent)
NED
(No Evident Disease)
0/0,0 18/72,0
Disease progression 2/50,0 1/4,0
DOD
(Died On Disease)
2/50,0 6/24,0
Total 4/100,0 25/100,0